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ABSTRACT 
 
GEOGHEGAN, JOHANNA. Follicle Stimulating Hormone Receptor Resides 
in Detergent Resistant Membrane Microdomains. Department of Biological 
Sciences, June 2011. 
 
ADVISOR: Professor Brian Cohen 
 
 Follicle stimulating hormone (FSH) is an anterior pituitary glycoprotein hormone 
crucial for proper spermatogenesis in males and oocyte development in females. The 
follicle stimulating hormone receptor (FSHR) is a G-protein coupled receptor found 
exclusively on the membranes of Sertoli cells in the testes and granulosa cells in the 
ovaries.  It has been proposed that FSHR localizes to detergent resistant portions of the 
membranes called lipid rafts, which are membrane microdomains that contain a high 
percent composition of cholesterol and sphingolipids.  To determine if FSHR resides in 
these membrane microdomains, strong detergents were used to extract and isolate 
detergent resistant membranes.  Prior to extraction, cells were treated with FSH and/or 
the cholesterol depleting drug methyl- β-cylcodextrin (MβCD), and western blot analysis 
was conducted.  FSHR was observed in both the detergent soluble and insoluble portions 
of the membrane, suggesting that there are two populations of FSHR, and the receptor is 
more likely to reside in lipid raft or detergent resistant fractions.  FSH treatment resulted 
in increased FSHR residency in lipid rafts fractions. Understanding FSHR residency in 
the plasma membrane may lead to greater understanding of its signaling pathways and 
potential human health implications for infertility treatment and contraception 
development.
 1 
INTRODUCTION 
The endocrine system is an intricate communication system between parts of the 
brain and various target organs involved in reproduction, metabolism, and immune 
response.  Communication is achieved through hormones, chemical messengers which 
travel to targets through the blood stream. Response to a hormone is determined by the 
presence of a hormone specific receptor on the target cell, and the resulting signal 
transduction may cause modification of proteins and upregualtion or inhibition of the 
expression of specific genes.1 
Follicle stimulating hormone (FSH) is a hormone involved in the hypothalamic-
pituitary-gonadal axis, and it is essential for gonad maturation and gamate formation in 
males and females. FSH is a member of the glycoprotein hormone family, which also 
includes thyroid stimulating hormone, chorionic gonadotropin, and luteinizing hormone.  
Glycoprotein hormones are heterodimers that share a common alpha subunit but contain 
distinct hormone specific beta subunits.1,2 FSH is secreted by the gonadotrophs in the 
anterior pituitary when stimulated by gonadotropin-releasing hormone from the 
hypothalamus. FSH binds to the follicle stimulating hormone receptor (FSHR) found 
exclusively anchored in the membranes of granulosa cells in the ovary and Sertoli cells in 
the testes.2  
In males, FSH promotes spermatogenesis by stimulating the Sertoli cells to 
release growth factors that support the developing sperm in the seminiferous tubules. 
Growth factors promote the maturation of primary spermatocytes to haploid secondary 
spermatocytes to spermatids and then finally into mature spermatozoa.1 
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In females, FSH stimulates the maturation of primordial follicles to mature 
vesicular follicles in the ovary by activating more than 100 different target genes 
involved in cellular proliferation, differentiation, antrum formation and oocyte maturation 
in the granulosa cell (Figure 1).  Follicles contain the oocyte, which is surrounded by the 
granulosa cells, a basal lamina, and peripheral thecal cells.3 Granulosa cells, as a result of 
the maturation of follicles, produce estrogen. Estrogen is involved in expression of 
secondary sex characteristics and stimulation of luteinizing hormone secretion, which is 
responsible for the rupturing of the mature vesicular follicles, or ovulation.3  
 
Figure 1: Maturation of ovarian follicles in ovary4  
The function of a receptor is to relay extracellular stimuli, such as the presence of 
a hormone, to intracellular effector molecules. The FSHR is a G-protein coupled receptor 
(GPCR), and is composed of 695 amino acids. The mature glycosylated receptor ranges 
from 75 to 76.5 kDa.5 A representaion ot the FSHR can be seen in Figure 2. The 
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transmembrane domain of the receptor contains seven hydrophobic transmembrane alpha 
helices connected by alternating extracelluar and intracellular loops, which is typical of 
GPCRs.5 Additionally, the FSHR has a putative caveolin interaction motif, 
ΦXΦXXXXΦXX, in the fourth transmembrane domain that may influence the location 
of its residency in the plasma membrane.6 The receptor also contains an extracellular N-
terminus, and an intracellular C-terminus.7 The extracellular domain has notable leucine 
rich repeats throughout, which are thought to help with interaction between this domain 
and hormone. There are also four potential N-linked glycosylation sites in the 
extracellular domain of human FSHR that could be involved in hormone binding or 
proper protein folding.5   
 
Figure 2: Representation of FSHR displaying the extracellular domain, seven pass 
transmembrane domain with its alternating intracellular and extracellular loops, and the 
intracellular domain.8   
 
 The binding of a ligand to a GPCR induces a conformational change in the 
receptor that enables it to activate a G-protein. G-proteins are heterotrimeric and 
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composed of an α, β, and γ subunits. In its inactive state, the α subunit is bound to GDP, 
but when activated by the receptor, the α subunit binds GTP. Once activated, the α 
subunit dissociates from the βγ subunit and stimulates downstream effector molecules. 
The α subunit has intrinsic GTPase activity, and is therefore able to terminate the signal 
once intracellular signaling cascades have been initiated.9 
The binding to FSH to its receptor results in the rapid and efficient activation of 
intracellular signaling cascades that activate various genes in the granulosa and Sertoli 
cells. The well-characterized signaling cascade activated by the FSHR involves adenylyl 
cyclase and the associated G-protein, Gαs.
10 Adenylyl cyclase stimulates cAMP, which 
ultimately activates cAMP-dependent protein kinase or PKA. PKA phosphorylates 
transcription factors that regulate gene expression (Figure 3).9 
 
Figure 3:  Signal transduction pathway activated by FSH that involves activation of Gs 
and ultimately PKA 4 
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However, FSHR is also capable of activating other signaling cascades such as the 
EPAC/RAP1 and SRC/RAS/EGFR/MAPK kinase pathways.10 Furthermore, the PKA 
pathway generally associated with FSH can also activate multiple additional downstream 
molecules such as p38MAPK and phosphatidylinositol-3 kinase.3  
Although GPCRs are able to efficiently activate multiple signaling cascades, G-
proteins and associated enzymes are present at low concentrations in mammalian cell 
membranes. A potential explanation for this discrepancy is receptor localization or 
residency in membrane microdomains such as lipid rafts.  Lipid rafts are areas of the cell 
membrane that display less fluidity and increased resistance to non-ionic detergents due 
to the high percent composition of cholesterol and sphingolipids such as sphingomyelin.11   
 
 
 
 
 
 
 
 
Figure 4: Visual of lipid raft in plasma membrane. Lipid rafts are enriched for 
cholesterol, sphingolipids, and signaling molecules.14  
 
Lipid rafts are enriched for signaling molecules such as G-proteins, GPI-anchored 
proteins, and adenylyl cyclase.12 A depiction of the components of lipid rafts can be 
found in Figure 4. Lipid rafts may facilitate signal transduction by both providing an 
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arrangement in which signaling components are present in increased concentrations at the 
site of a potentially active receptor and excluding proteins that could potentially interfere 
with signal transduction, such as membrane phosphatases.13 Thus, lipid rafts may 
function as “signaling platforms.”12   
 Previous research in the Cohen lab suggested that disrupting lipid rafts interferes 
with the receptor’s ability to activate downstream signaling components, specifically 
adenylyl cyclase and the production of cAMP. Lipid rafts were disrupted with the 
cholesterol depleting drug methyl- β-cylcodextrin (MβCD). While some proteins are 
confined to membrane microdomains,  MβCD treatment disrupts lipid rafts in live cells 
such that proteins are no longer confined.12  Figure 5 shows that treatment with MβCD is 
associated with a decrease in cAMP production, one of FSHR’s downstream signaling 
molecules. Thus, creating cells with effectively no lipid rafts by depleting cholesterol 
with MβCD interfered with the FSHR ability to activate cAMP.  
 
 
 
 
 
 
 
 
Figure 5: Cholesterol removal with MβCD abrogated cAMP production by HEK293-
hFSHR cells. MβCD treatment reduced cAMP production significantly at hFSH doses of 
10ng, 100ng, and 1000ng.  Removal of MβCD after the 1 hour pretreatment allowed the 
cells to partially recover, as observed in the difference between treated and cells with the 
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drug removed (washout) at 100ng and 1000ng hFSH. Each point represents triplicate 
treatments measured in triplicate.15 
 
 FSHR may associate with a specific kind of lipid raft, known as caveolae. 
Caveolae are similar in composition to lipid rafts but are further characterized by the 
presence of the protein caveolin.13 Caveolin is a hair-pin like protein responsible for the 
unique shape of the caveolae, which is often described as a cave-like invagination in the 
cell membrane that is approximately 50 to 100 nm.6  A illustration of caveolae, including 
a morphological comparison to lipid rafts, is shown in Figure 6. Caveolae are found in 
many types of cells and are involved in phagocytosis, endocytosis, transcellular 
movement, and cell signaling.16 Insel et al. found that GPCR and associated signaling 
components localize to caveolae and that caveolae disruption resulted in altered GPCR 
signaling.11 
 
 
 
 
 
 
 
 
 
 
Figure 6: Caveolin causes the characteristic flask shape of caveolae 17  
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 Further evidence that FSHR may reside in membrane microdomains such as lipid 
rafts or caveolae includes a putative caveolin interaction motif found in the 
transmembrane domain of the receptor.  A caveolien interaction motif is a conserved 
amino acid sequence that causes proteins to localize to caveolae. There are three known 
caveolin interaction motifs, ΦXΦXXXXΦ, ΦXXXXΦXXΦ, and ΦXΦXXXXΦXX, 
where Φ represents Trp, Phe, or Tyr, and X represents any amino acid.6 FSHR contains 
the last caveolin interaction motif in the 4th intracellular transmembrane domain with the 
amino acid sequence FAFAAALFPIF. This sequence is highly conserved among FSHR 
amino acid sequences in pigs, cows, sheep, mice, and humans (Figure 7).  Conservation 
of this motif across species suggests that it may be important for receptor function. 
 
Figure 7: Caveolin Interaction Motif found in the fourth transmembrane domain in 
FSHR. The large letters represent amino acids that were conserved across pigs, cows, 
sheep, mice, and humans. The smaller letters show where there is some discrepancy in 
amino acid sequence. The caveolin interaction motif is highly conserved.17  
 
 Other GPCRs are known to reside in or localize to lipid rafts when bound by an 
agonist include the angiotensin II (AT-1), serotonin (5HT), gonadotrophin releasing 
hormone, and oxytocin receptors.13 Smith and Roess et al. have demonstrated that the 
luteinizing hormone receptor (LHR), a hormone receptor closely related to the FSHR, 
also localizes to lipid rafts when stimulated by chorionic gonadotropin hormone.  They 
also found that disruption of lipid rafts with MβCD reduced cell signaling through cAMP. 
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However, they did not find that disruption of caveolae resulted in altered cell signaling 
through the LHR.12 It is interesting to note at this point that the luteinizing hormone 
receptor only contains a partial putative caveolin interaction motif in the second 
transmembrane domain. Furthermore, Smith and Roess found that the location of the 
receptor was dependent on the presence of hormone. Cell membrane fractions were 
obtained through sucrose gradient fractionation, and when cells were treated with 
chorionic gonadotropin hormone, functional LHR localized to low density, detergent 
insoluble membrane fractions with properties consistent with lipid rafts. Without 
hormone treatment, LHR was found in the bulk membrane.13  
 To characterize the residency of FSHR in the cell membrane, portions of cell 
membranes of HEK-293 cells that express human FSHR were extracted using detergents 
of varying strengths.  Detergents were used to isolate detergent resistant fractions, or 
microdomains such as lipid rafts and caveolae, and detergent susceptible fractions. The 
resulting cell membrane fractions were subjected to SDS PAGE and western blot analysis 
in which antibodies specific to FSHR were employed to identify the receptor’s location. 
In additional experiments, HEK-293 hFSHR cells were treated with MβCD to determine 
if lipid raft and caveolae disruption influenced receptor residency and FSH to determine 
if hormone treatment influences the receptor’s location. Understanding the FSHR and its 
ability to transduce a hormone signal, which may be connected to receptor localization to 
lipid rafts or caveolae, may provide insight for potential pharmaceutical interventions for 
infertility treatments and alternative forms of contraception. 
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METHODS 
Cell Culture 
 Human embryonic kidney (HEK 293) cells were stably transfected with human 
FSHR and incubated in filtered Dulbecco’s Modified Eagle’s Medium (DMEM) 
containing fetal bovine serum and penicillin and streptomycin solution.18  
 
Membrane Extraction 
 Cell culture media was aspirated from four 75cm2 cell culture flasks at 100% 
confluency. Five ml of serum free DMEM media was added to one flask, and 5 ml of 
serum free DMEM media with 2 µl of human FSH was added to the other flask. The 
flasks were incubated at 37°C for 1 hour. In experiments that included treatment with 
MβCD, four flasks at 100% confluency were used. Five ml of serum free DMEM media 
were added to two flasks, and 5 ml of serum free DMEM media with 0.066 grams of 
MβCD was added to the other two flasks. The four flasks were incubated at 37°C for 1 
hour. Two µl of human FSH were then added to one flask treated with MβCD and one 
flask that was not treated with MβCD. All flasks were subsequently incubated for 30 min 
at 37°C.  
All media was then aspirated from the flasks and washed gently with 5 ml of 
1xphosphate buffered saline (PBS). The 1x PBS solution was then aspirated, and 5 ml of 
1XPBS with 5mM of EDTA was added to each flask and allowed to incubate for 5 
minutes. The cell suspension was then transferred into 15ml conical tubes and 
centrifuged at 3000RPMs for 10 minutes.  
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 Pellets were resuspended with 1 ml of 1XMES buffered saline (MBS) and 1% 
triton with protease inhibitors. Samples were then vortexed well, transferred to dounce 
homogenizers, and dounced for 10 strokes. Afterwards, samples were transferred to 
microfuge tubes and centrifuged at 15,000g at 4°C 10 minutes. The supernatant 
represented membrane proteins extracted with triton, or detergent soluble membrane 
extracts. The pellet was resuspended with 1 ml 1xMBS and 2% sodium dodecyl sulfate 
(SDS). Samples were then vortexed and transferred to dounce homogenizers and dounced 
10 times. The SDS extracts, or detergent resistant membrane extracts, were centrifuged 
once more and sonicated. 
 
SDS-PAGE Electrophoresis 
 A 7.5% resolving gel mixture was made that contained 7.5 ml of water, 3.75 ml of 
30% acrylamide and 0.8% bis-acrylamide, 3.75 ml 4x running buffer, 150 µl of 10% 
SDS, 50µl of 10% APS, and 10µl of TEMED. The resolving gel polymerized for 
approximately 50 minutes with isopropanol layered on top. After the resolving gel 
polymerized, the isopropanol was removed, and the 4% stacking gel was added. The 
stacking gel contained 6.1 ml of water, 1.3 ml of 30% acrylamide and 0.8% bis-
acrylamide, 2.5 ml of 4x stacking buffer, 100µ1 of 10% SDS, and 20µl of TEMED.  
Before the stacking gel polymerized, a 10 well comb was added, and the gel polymerized 
in approximately 40 minutes.   
 Protein concentrations were determined by BCA Protein Assays Kit (Pierce) so 
that a uniform amount of protein was loaded into each lane of the electrophoresis gel.  
Samples were heated at 100°C for 5 minutes before conducting electrophoresis. A 
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prestained SDS-Page broad range molecular weight standard was used (either Prosieve 
color protein marker or Color Plus prestained broad range protein marker from New 
England Biolabs). Electrophoresis was performed for approximately 30 minutes at 100 
volts until the samples migrated through the stacking gel. For the remainder of the time, 
electrophoresis was conducted at 150 volts.  
 
Gel Transfer 
  The gels were incubated in transfer buffer for 5 minutes and the membrane was 
dipped in methanol for 10 seconds and then incubated in transfer buffer for 5 minutes. 
The samples were transferred from the gel to a 3 ¼” x 2” polyvinyl difluoride (PVDF) 
membrane using a semi-dry transfer cell (Bio-Rad). The electrophoresis gel was placed 
on top of the membrane and three pieces of 3 ¼” x 2” Whatman paper were placed on 
either side. The transfer process was conducted for 15 minutes at 15 volts.   
 
Immunoblotting/Western Blot Analysis 
 Blots were blocked using 20 ml of milk (5 grams of powdered milk in 100 ml of 
1xTBST) overnight at 4°C on a rocker. Primary antibody was then added (5µl in 10 ml of 
milk) and allowed to incubate for an hour at room temperature. Monoclonal primary 
antibodies to FSHR were used for one blot and monoclonal primary antibodies to 
cadherin, gamma-tubulin, or Flotillin-2 were used for the other blot. (Anti-FSHR 
antibody from James A. Dias Lab, Wadsworth Center, State University of New York at 
Albany; Anti-cadherin antibody from Sigma; Anti-Flotillin-2 antibody from Cell 
Signaling) The blots were then washed with 50 ml of 1xTBST three times for five 
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minutes each wash. The blots were incubated in secondary antibody (2 µl in 10 ml of 
milk) for 1 hour at room temperature on a rocker. HRP goat anti mouse secondary 
antibody was used for blots probed with FSHR primary antibody, blots probed with 
gamma-tubulin primary antibody, and blots probed with cadherin primary antibody 
(Jackson Immunological Laboratories). Blots probed for flotillin-2 were incubated in 
primary antibody overnight at 4°C on a rocker. The blots were then washed with 
1xTBST, incubated in secondary antibody, washed with 1xTBST, and developed as 
described above.  Goat anti rabbit secondary antibody was used for blots probed with 
Flotillin-2 primary antibody (Invitrogen). Blots were then washed three times with 50ml 
of 1xTBST for five minutes for each wash. After the final wash, the blots were developed 
using super signal west pico chemiluminescent substrate (Thermo Scientific). Each blot 
was covered with 2 ml of the peroxide solution and 2 ml of enhancer solution (combined 
just before application) for five minutes. Images were obtained using a FujiImager on 
chemiluminescent setting.   
 
RESULTS 
FSHR found in 2% SDS membrane fractions, primarily in the presence of FSH 
 
 The results of the membrane extraction process, SDS PAGE and western blot 
analysis probed for FSHR can be seen in Figure 8. FSHR has a molecular weight of 79 
kDa, but the higher molecular weight observed may be due different glycosylation 
patterns of the receptor. The higher than expected molecular weight is consistent with the 
findings of other researchers.5 The receptor is found primarily in the cellular membrane 
fractions extracted with 2% SDS, although less distinct bands are present in the 1% triton 
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membrane fractions as well. Additionally, the FSHR is more likely to be found in the 2% 
SDS membrane fractions in the presence of FSH.  
 
 
Figure 8: Cellular membrane fractions subjected to SDS-PAGE and western blot analysis 
using a monoclonal anti-FSHR antibody 
 
 In order to confirm the validity of the cellular membrane extraction process, 
Western blot analysis was performed for proteins that are known to reside in lipid rafts 
and those that are known to reside in the bulk membrane. Figure 9 represents western blot 
analysis probed with a monoclonal anti-Flotillin-2 antibody.  Flotillin-2 is a membrane 
protein known to reside in lipid rafts in HEK 293 cells.19 Flotillin-2 has a molecular 
weight of 42 kDa, which suggests that the bands observed in Figure 9 do represent the 
protein. The strongest band is present in the 2% SDS fractions. The bands in the 1% 
Triton fractions are faint.  
 
Figure 9: Cellular membrane fractions subjected to SDS-PAGE and western blot analysis 
using a monoclonal anti-flotillin-2 antibody 
121 
85 
- + + 
Detergent: 
hFSH: 
1% Triton 2% SDS 
- 
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 Western blot analysis was also conducted with a monoclonal anti-cadherin 
antibody. Cadherin is a membrane protein involved in cell adhesion that resides in lipid 
rafts in many cell types. Cadherin was detected at the appropriate molecular weight of 
124 kDa (Figure 10).20  These results show that cadherin was primarily found in the 2% 
SDS fractions. Less distinct bands are also present in the 1% Triton fractions.  
 
 
Figure 10: Cellular membrane fractions subjected to SDS-PAGE and western blot 
analysis using a monoclonal anti-cadherin antibody 
 
 Additionally, a monoclonal anti-gamma-tubulin antibody was used for western 
blot analysis of gamma-tubulin. Gamma-Tubulin is a cytoplasmic protein and component 
of centrosomes. It would therefore not be expected in lipid rafts.21,22 Gamma-tubulin was 
detected at the appropriate molecular weight of 48 kDa (Figure 11). Discrete bands are 
present in the 1% triton fractions.   
 
Figure 11: Cellular membrane fractions subjected to SDS-PAGE and western blot 
analysis using a monoclonal anti-gamma-tubulin antibody 
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MβCD treatment disrupted FSHR residency in 2% SDS fractions 
 Prior to cellular membrane extraction, HEK 293 hFSH were treated with MβCD 
(in addition to FSH). SDS-PAGE and western blot analysis were performed using a 
monoclonal anti-FSHR antibody. The 2% SDS fractions can be seen in Figure 12. There 
are no distinct bands in the 2% SDS fractions treated with FSH and MβCD. There are 
distinct bands in the remaining 2%SDS fractions which include no treatment with FSH 
and MβCD, just treatment with FSH, and just treatment with MβCD.  
 
Figure 12: 2% SDS cellular membrane fractions treated with FSH and MβCD to disrupt 
lipid rafts. Fractions subjected to SDS-PAGE and western blot analysis using a 
monoclonal anti-FSHR antibody as described above. 
 
 
DISCUSSION 
 
Lipid rafts are densely packed microdomains that display a resistance to nonionic 
detergents due to the increased presence of cholesterol and sphingolipids with saturated 
acyl chains. Due to the resistance to nonionic detergents that is inherent to lipid rafts by 
definition, it can be concluded that the 2% SDS or detergent resistant fractions represent 
lipid rafts. It can also be concluded that the 1% triton or detergent susceptible fractions 
represent bulk membrane. 
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FSHR resides in both lipid rafts and bulk membrane 
 My results indicate that there are two populations of FSHR. The receptor is 
present at increased concentrations in the lipid rafts; however, FSHR is also present in the 
bulk membrane at decreased concentrations. Furthermore, treatment with FSH increases 
the residency of FSHR in lipid rafts. The methods for this investigation are supported by 
western blot analysis of membrane fractions probed with monoclonal antibodies to 
flotillin-2, cadherin, and gamma tubulin. Flotillin-2 is a marker protein for lipid rafts in 
HEK-293 cells, and these methods produced results that were consistent with this. 
Although a more pronounced band was expected in the lipid rafts fractions not treated 
with hormone, this inconsistency may be due to a transfer error during western blot 
analysis. Nonetheless, these results are strong indications that the method utilized to 
isolated lipid rafts was effective. Cadherin is also a protein that has been shown to reside 
in lipid rafts, and the results support this.  Gamma tubulin is not a protein found in lipid 
rats, and the results show that gamma tubulin resided primarily in the bulk membrane.  
 
Disruption of lipid rafts with MβCD alters FSHR residency in lipid rafts 
 When HEK-293 hFSHR cells were treated with MβCD, the normal pattern of 
FSHR residency in lipid rafts was altered. FSHR was no longer present at increased 
concentrations in lipid rafts.  This finding suggests that FSHR resides in lipid rafts 
because if FSHR did not reside in lipid rafts, the distribution would not change. However, 
it would be expected that without MβCD treatment, most FSHR would then reside in 
lipid raft fractions upon FSH stimulation. However, the results are not consistent with 
this expectation.  
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 The use of detergents to extract membrane fractions, specifically lipid rafts and 
caveolae, has been criticized. Eddin suggested that use of detergents for membrane 
fractionation can create membrane blebbing, fusion, and reorganization of lipids from 
their natural state. He also explored evidence that membrane solubilization with 
detergents could be temperature dependent.23  All of these can cause inaccurate or 
inconsistent results. Due to these criticisms, inconsistencies of FSHR residency in lipid 
rafts in the experiments with MβCD, and the fact that my western blot analysis of 
membrane fractions probed with monoclonal antibodies to FSHR were not always as 
clear as those presented here, suggests that additional methods of membrane fractionation 
should be explored. Other methods of lipid raft isolation employ sodium carbonate to lyse 
cells and the use of a discontinuous sucrose gradient and ultracentrifugation to separate 
lipid rafts by density (sucrose density fractionation). 24, 25 Lipid rafts are found in the less 
dense, buoyant fractions in the sucrose gradient, which is most likely due to the high lipid 
to protein ratio.26 Sucrose density fractionation, however, requires ultracentrifugation for 
16 to 20 hours, and when used by Song et al, was found to have significant contamination 
of lipid raft fractions with other non lipid raft proteins such as transferrin receptor.24  
Another detergent free method conducted by Smart et al used an isotonic buffer with 
EDTA to lyse cells and a Percoll gradient to separate membrane fractions. Smart et al did 
not have as much contamination, but did experience poor yield.24,26  Macdonald and Pike 
developed a fractionation method in which the buffer used to lyse the cells did not 
contain EDTA but instead contained the divalent cations magnesium and calcium. An 
Optiprep gradient and ultracentrifugation was then used to separate raft fractions from 
non-raft fractions. This last method appears to be fairly consistent, requires less time, and 
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does not show significant contamination. Macdonald and Pike suggested that the success 
of their detergent free method was due to the removal of EDTA. The divalent cations 
may stabilize the rafts such that they are more readily isolated.  Detection of lipid raft 
proteins was done through western blot analysis in these varying detergent free 
methods.24 None of these methods, however, were performed in HEK-293 cells. 
Comparison of the results of these detergent free methods of membrane fractionation and 
lipid raft isolation to the detergent fractionation employed in this study would validate the 
results obtained here.  
 Other areas to explore to further investigate FSHR residency in lipid rafts includes 
the mutagenesis of the putative caveolin interaction motif present in FSHR that may 
cause it to be located to the specific subset of lipid rafts known as caveolae. Furthermore, 
fluorescent microscopy techniques could be employed to observe if FSHR co-localizes 
with the caveolae marker protein caveolin with fluorescently tagged antibodies.  
 Understanding the residency of FSHR in membrane microdomains can help 
further knowledge in FSHR and GPCR signaling. This has important implications for 
human health. Specifically, FSHR and its signaling components and properties could be a 
pharmaceutical target for infertility treatment and contraception development, as 
previously mentioned. Furthermore, GPCRs are heavily involved in currently available 
pharmaceutical drugs, and increasing our understanding of how they work is beneficial.27 
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